
Selective targeting of the HIV-1 reverse transcriptase catalytic complex through interaction with the “primer grip” region by pyrrolobenzoxazepinone non-nucleoside inhibitors correlates with increased activity towards drug-resistant mutants
Keywords: مدل سازی مولکولی; HIV-1; Reverse transcriptase; NNRTIs; Kinetics; Drug resistant; Molecular modeling